Compare KALV & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALV | GPOR |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.2M | 4.1B |
| IPO Year | N/A | N/A |
| Metric | KALV | GPOR |
|---|---|---|
| Price | $17.00 | $207.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $26.43 | ★ $225.67 |
| AVG Volume (30 Days) | ★ 1.6M | 248.8K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,426,000.00 | ★ $1,231,668,000.00 |
| Revenue This Year | N/A | $57.17 |
| Revenue Next Year | $204.16 | $8.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 38.91 |
| 52 Week Low | $7.30 | $153.27 |
| 52 Week High | $17.28 | $225.78 |
| Indicator | KALV | GPOR |
|---|---|---|
| Relative Strength Index (RSI) | 70.46 | 50.59 |
| Support Level | $15.88 | $203.00 |
| Resistance Level | $17.10 | $222.87 |
| Average True Range (ATR) | 1.08 | 6.40 |
| MACD | 0.22 | -2.11 |
| Stochastic Oscillator | 96.52 | 26.92 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.